Literature DB >> 15536116

What is the optimal blood pressure and drug therapy for patients with coronary artery disease?

Carl J Pepine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15536116     DOI： 10.1001/jama.292.18.2271

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

1.  Association between visit-to-visit blood pressure variability and adverse events in coronary artery disease patients after coronary intervention.

Authors:  Tsung-Ying Tsai; Hsin-Bang Leu; Pai-Feng Hsu; Ya-Ling Yang; Su-Chan Chen; Shao-Sung Huang; Wan Leong Chan; Shing-Jong Lin; Jaw-Wen Chen; Ju-Pin Pan; Min-Ji Charng; Ying-Hwa Chen; Tao-Cheng Wu; Tse-Min Lu; Po-Hsun Huang; Hao-Min Cheng; Chin-Chou Huang; Shih-Hsien Sung; Yenn-Jiang Lin; Cheng-Hsueh Wu
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-09-12       Impact factor: 2.885

2.  Intensive blood pressure treatment in coronary artery disease: implications from the Systolic Blood Pressure Intervention Trial (SPRINT).

Authors:  Jiabin Zang; Jianwen Liang; Xiaodong Zhuang; Shaozhao Zhang; Xinxue Liao; Guifu Wu
Journal:  J Hum Hypertens       Date:  2021-02-15       Impact factor: 3.012
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.